A certificate of analysis (CoA) is the document in which a supplier reports the results of analyses it carried out, or had carried out, on a batch of raw material; on its own it does not prove that the delivered material is that batch or that it meets your acceptance criteria. The Cosmetic Good Manufacturing Practices Guideline of the Turkish Medicines and Medical Devices Agency (TİTCK) requires raw materials to be bought from approved suppliers and documents showing they meet acceptance criteria to be kept, but it also holds the raw material in quarantine until quality control approval. The CoA is one input to that approval. Which raw materials also need independent measurement on top of the document is a risk-based decision.
What does a certificate of analysis tell you?
A typical CoA gives the raw material's name, the batch number, the manufacturing date and the expiry or retest date, the parameters measured, the specification limits for those parameters, the results found and the person who approved the document. It shows that the supplier released that batch against its own specification.
That is as far as it goes. Which method was used, who carried out the analysis and whether the supplier's specification matches what your product needs cannot always be read from the document.
What does the law require at raw material intake?
Article 11 of Türkiye's Regulation on Cosmetic Products requires cosmetic products to be manufactured in line with good manufacturing practice. Compliance is presumed where manufacture follows harmonised standards whose references have been published in the Official Journal of the European Union.
With an announcement dated 18 September 2026, TİTCK updated its Cosmetic Good Manufacturing Practices Guideline (KDD-KLVZ-01), which rests on Cosmetics Law No. 5324, the Regulation on Cosmetic Products and the TS ISO EN 22716 standard. The guideline's second revision took effect on 11 September 2026. Its main provisions on raw material intake are these:
| Guideline clause | What it requires |
|---|---|
| 11.2.1 | Raw materials are bought only from approved suppliers; documents showing they meet acceptance criteria (technical specification, certificate, etc.) are kept. |
| 11.2.2 | At every delivery, container integrity, whether containers are closed, agreement between the delivery note and the label, and any sign of contamination or damage are checked and recorded. |
| 11.2.3 | Raw material waits in a marked quarantine area until quality control approval is given. |
| 11.2.4 | If a delivery consists of more than one batch, a separate sample is taken from each batch. |
| 12.1.1 | The quality control unit must prove that product and material quality meets the acceptance criteria. |
| 12.2.3 | A sample must be able to represent the whole batch of the material it was taken from. |
| 12.3.1 | Starting materials are analysed by suitable methods under predefined procedures to confirm they meet acceptance criteria, and detailed records are kept. |
| 12.4.2 | Samples of starting materials are kept for at least two years from release of the product. |
The wording is worth noting: keeping documents is the first step, while the burden of proof sits with the quality control unit. The guideline does not list which analysis to run for each raw material; acceptance criteria and methods are defined in the company's own written procedures. Check the current text of the guideline on the TİTCK website before applying it.
What does the safety report require about raw materials?
Annex I/B of the regulation sets out the minimum content of the cosmetic product safety report. Item 1 of Part A requires the quantitative and qualitative composition of the product, and item 4 requires:
- The purity of the substances and mixtures.
- In the case of traces of prohibited substances, evidence of their technical unavoidability.
- The relevant characteristics of the packaging material, in particular purity and stability.
Article 20 of the regulation also permits the unintended presence of a prohibited substance, stemming from impurities, the manufacturing process, storage or packaging, where it is technically unavoidable under good manufacturing practice and the product is safe. Both the purity information and the evidence of technical unavoidability rely heavily on data coming from the raw material. The first source of that data is often the supplier's CoA, and the safety assessor wants to know how far the document can be trusted.
In the EU's Regulation (EC) No 1223/2009 on cosmetic products, item 4 of Annex I Part A contains the same three headings, and Article 8 the same good manufacturing practice obligation.
What does a CoA not prove?
- That the delivered material is that batch. The document belongs to a batch; the label and records say the drum in your warehouse is from that batch, but only measurement confirms its contents.
- How the analysis was done. TİTCK's Guideline on the Analysis of Cosmetic Products (KÜD-KLVZ-39, Rev.02) requires analyses to follow the principles of TS EN ISO/IEC 17025, and in choosing a method gives preference, in order, to methods set by the Agency, TSE, ISO or CEN standards, international harmonised protocols, methods validated in inter-laboratory ring trials and single-laboratory validated methods. Where a supplier's method sits in that order often cannot be told from the CoA.
- That the specification meets your needs. The supplier releases against its own specification. An impurity or active level that is critical for your product may not appear in it at all.
- That nothing changed in transport and storage. The document describes the state before shipment.
When should independent measurement be done?
Re-analysing every raw material in every batch is not realistic for most sites. The approach used in practice is to differentiate by risk. In the following situations, a measurement on top of the CoA is usually justified:
| Situation | Why |
|---|---|
| New supplier or new site | There is no track record on how reliable the documents are. |
| Change of source, origin or production method | The impurity profile may change; the safety report may need updating. |
| An active ingredient that carries a marketing claim | It is the basis for the percentage on the label. |
| High-value raw material | There is an economic reason for substitution or dilution. |
| Raw material with a prohibited or restricted substance risk | Evidence of technical unavoidability is required. |
| Mismatch between CoA and delivery | Batch number, date or appearance do not agree. |
| Complaint or deviation | You need to tell whether the problem came from the raw material. |
The measurement result is compared with the document. If they agree, trust in the supplier rests on data, and measurement frequency can be reduced for later batches. If they do not, the raw material stays in quarantine and the matter is settled with the supplier at the point of intake, before it reaches the product.
Why do retained samples matter?
Clause 12.4.2 of the guideline requires samples of starting materials to be kept for at least two years from release of the product. These samples are the only way to measure, after the fact, whether a problem raised by a complaint or inspection months later came from the raw material. If the sample container does not carry the batch number and sampling date (12.2.4), that link cannot be made. We described how the batch record should reach back to the raw material in a batch number is not a batch identity.
Frequently asked questions
Is accepting raw material on the supplier's CoA against the rules? No. The guideline requires documents showing the acceptance criteria are met and lists certificates among them. But the raw material waits in quarantine until quality control approval, and the quality control unit must be able to prove the basis of the acceptance decision.
Must every raw material batch be analysed? The guideline requires a separate sample from each batch and confirmation of compliance with acceptance criteria under procedure; it does not list which parameter is measured how often. That is set in the company's written procedure and risk assessment.
Must the analysis be done in an accredited laboratory? TİTCK's analysis guideline requires analyses to follow the principles of TS EN ISO/IEC 17025. Which documentation is required for a specific analysis should be confirmed against the current guideline text and with your responsible technical person.
Is the rule different for exports to the EU? Regulation 1223/2009 requires good manufacturing practice (Article 8) and the purity and impurity information in the safety report (Annex I) in the same way. The prohibitions and limits in the target market's current annexes should be checked separately.
What does Kozvex do at intake?
Kozvex's supplier verification is built for this step: it confirms, before production, that the raw material received from the supplier is the material ordered, and records whether the supplier's certificate of analysis matches the delivered material. Scanning is done at your site with the handheld device and the mobile app; where a decision is needed, the sample is sent to a contracted accredited laboratory. The record does not replace your quality control unit's acceptance decision or the safety assessment. Detail is on the solutions and how we work pages.
Sources
- Regulation on Cosmetic Products, Official Gazette, 8 May 2023, No. 32184 (Repeated) (in Turkish)
- TİTCK, Cosmetic Good Manufacturing Practices Guideline, KDD-KLVZ-01, Revision 2 (11.09.2026) (in Turkish)
- TİTCK, About the Updated Guideline (18.09.2026) (in Turkish)
- TİTCK, Guideline on the Analysis of Cosmetic Products, KÜD-KLVZ-39, Rev.02 (in Turkish)
- Regulation (EC) No 1223/2009 on cosmetic products


